Abstract
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited form of cardiomyopathy with low penetrance and variable expressivity. Dominant mutations and rare polymorphisms in desmosome genes are frequently identified. We reasoned that individuals with earlier onset disease would have more frequent desmosome gene mutations and rare polymorphisms. Three groups were compared: Young with symptoms attributable to ARVD/C or a diagnosis of ARVD/C at age of 21 years or earlier, Middle with first symptoms or diagnosis age of 22–49 years, and Late with first symptoms or diagnosis at age of 50 or more years. deoxyribonucleic acid (DNA) sequence analysis was performed on five cardiac desmosome genes, and the presence of mutations and rare missense polymorphisms was compared among the three groups. In the entire Young cohort, 20 (67%) had one or more cardiac desmosome gene mutations. The prevalence of cardiac desmosome gene mutations was similar in the Middle (48%) and Late (53%) cohorts (P = 0.23). Similar numbers of individuals in each cohort had more than one desmosome gene mutation, although the numbers are too small for statistical comparisons. The prevalence of certain rare missense DNA variants was not different among the cohorts (P = 0.71), yet these rare missense alleles were more prevalent in the overall study cohort of 112 ARVD/C participants compared to 100 race-matched controls (P = 0.027). The presence of these variants did not associate with the age of onset of ARVD/C or ventricular tachycardia. These findings highlight the complex interplay of environmental and genetic factors contributing to this condition.
Similar content being viewed by others
References
Awad, M. M., Calkins, H., & Judge, D. P. (2008). Mechanisms of disease: Molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nature Clinical Practice. Cardiovascular Medicine, 5, 258–267.
Corrado, D., & Thiene, G. (2006). Arrhythmogenic right ventricular cardiomyopathy/dysplasia: Clinical impact of molecular genetic studies. Circulation, 113, 1634–1637.
Dalal, D., Molin, L. H., Piccini, J., Tichnell, C., James, C., Bomma, C., et al. (2006). Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation, 113, 1641–1649.
Gerull, B., Heuser, A., Wichter, T., Paul, M., Basson, C. T., McDermott, D. A., et al. (2004). Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nature Genetics, 36, 1162–1164.
Awad, M. M., Dalal, D., Cho, E., Amat-Alarcon, N., James, C., Tichnell, C., et al. (2006). DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy. American Journal of Human Genetics, 79, 136–142.
Syrris, P., Ward, D., Evans, A., Asimaki, A., Gandjbakhch, E., Sen-Chowdhry, S., et al. (2006). Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. American Journal of Human Genetics, 79, 978–984.
Asimaki, A., Syrris, P., Wichter, T., Matthias, P., Saffitz, J. E., & McKenna, W. J. (2007). A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. American Journal of Human Genetics, 81, 964–973.
McKoy, G., Protonotarios, N., Crosby, A., Tsatsopoulou, A., Anastasakis, A., Coonar, A., et al. (2000). Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet, 355, 2119–2124.
Sen-Chowdhry, S., Syrris, P., & McKenna, W. J. (2005). Genetics of right ventricular cardiomyopathy. Journal of Cardiovascular Electrophysiology, 16, 927–935.
Awad, M. M., Dalal, D., Tichnell, C., James, C., Tucker, A., Abraham, T., et al. (2006). Recessive arrhythmogenic right ventricular dysplasia due to novel cryptic splice mutation in PKP2. Human Mutation, 27, 1157.
den Haan, A. D., Tan, B. Y., Zikusoka, M. N., Llado, L. I., Jain, R., Daly, A., et al. (2009). Comprehensive desmosome mutation analysis in North Americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation: Cardiovascular Genetics, 2, 428–435.
Dalal, D., Nasir, K., Bomma, C., Prakasa, K., Tandri, H., Piccini, J., et al. (2005). Arrhythmogenic right ventricular dysplasia: A United States experience. Circulation, 112, 3823–3832.
Taylor, G. P. (2009). The pathology of arrhythmogenic right ventricular cardiomyopathy. In A. R. Redington, G. S. VanArsdell, & R. H. Anderson (Eds.), Congenital diseases in the right heart (pp. 125–129). London: Springer.
Dalal, D., James, C., Devanagondi, R., Tichnell, C., Tucker, A., Prakasa, K., et al. (2006). Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology, 48, 1416–1424.
Sen-Chowdhry, S., Syrris, P., & McKenna, W. J. (2007). Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology, 50, 1813–1821.
Frigo, G., Bauce, B., Basso, C., & Nava, A. (2006). Late-onset arrhythmogenic right ventricular cardiomyopathy. Journal of Cardiovascular Medicine (Hagerstown), 7, 74–76.
McKenna, W. J., Thiene, G., Nava, A., Fontaliran, F., Blomstrom-Lundqvist, C., Fontaine, G., et al. (1994). Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. British Heart Journal, 71, 215–218.
Christensen, A. H., Benn, M., Tybjaerg-Hansen, A., Haunso, S., & Svendsen, J. H. (2010). Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients–disease-causing or innocent bystanders? Cardiology, 115, 148–154.
Posch, M. G., Posch, M. J., Geier, C., Erdmann, B., Mueller, W., Richter, A., et al. (2008). A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. Molecular Genetics and Metabolism, 95, 74–80.
Nishi, H., Kimura, A., Harada, H., Adachi, K., Koga, Y., Sasazuki, T., et al. (1994). Possible gene dose effect of a mutant cardiac beta-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy. Biochemical and Biophysical Research Communications, 200, 549–556.
Ingles, J., Doolan, A., Chiu, C., Seidman, J., Seidman, C., & Semsarian, C. (2005). Compound and double mutations in patients with hypertrophic cardiomyopathy: Implications for genetic testing and counselling. Journal of Medical Genetics, 42, e59.
Morita, H., Rehm, H. L., Menesses, A., McDonough, B., Roberts, A. E., Kucherlapati, R., et al. (2008). Shared genetic causes of cardiac hypertrophy in children and adults. The New England Journal of Medicine, 358, 1899–1908.
Bhuiyan, Z. A., Jongbloed, J. D., van der Smagt, J., Lombardi, P. M., Wiesfeld, A. C., Nelen, M., et al. (2009). Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: Results from a multicenter study. Circulation: Cardiovascular Genetics, 2, 418–427.
Fressart, V., Duthoit, G., Donal, E., Probst, V., Deharo, J. C., Chevalier, P., et al. (2010). Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Spectrum of mutations and clinical impact in practice. Europace, 12, 861–868.
Barahona-Dussault, C., Benito, B., Campuzano, O., Iglesias, A., Leung, T. L., Robb, L., et al. (2010). Role of genetic testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Clinical Genetics, 77, 37–48.
Basso, C., Thiene, G., Corrado, D., Angelini, A., Nava, A., & Valente, M. (1996). Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation, 94, 983–991.
Thiene, G., Nava, A., Corrado, D., Rossi, L., & Pennelli, N. (1988). Right ventricular cardiomyopathy and sudden death in young people. The New England Journal of Medicine, 318, 129–133.
Aronow, W. S., Mercando, A. D., & Epstein, S. (1995). Usefulness of an abnormal signal-averaged electrocardiogram for predicting cardiac death in elderly persons without heart disease. The American Journal of Cardiology, 75, 1273–1274.
Crotti, L., Lundquist, A. L., Insolia, R., Pedrazzini, M., Ferrandi, C., De Ferrari, G. M., et al. (2005). KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation, 112, 1251–1258.
Xu, T., Yang, Z., Vatta, M., Rampazzo, A., Beffagna, G., Pilichou, K., et al. (2010). Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. Journal of the American College of Cardiology, 55, 587–597.
Marcus, F. I., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., et al. (2010). Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed modification of the task force criteria. Circulation, 121, 1533–1541.
Cox, M. G. P. J., van der Smagt, J. J., Noorman, M., Wiesfeld, A. C., Volders, P. G. A., van Langen, I. M., et al. (2010). Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnostic task force criteria: Impact of new task force criteria. Circulation: Arrhythmia Electrophysiology, 3, 126–133.
Acknowledgments
This work was supported by funding from the National Institutes of Health (HL088072 to DPJ), the France-Merrick Foundation, JHU Friends in Red, and the Jeff Cooper CARE Foundation. The authors would also like to acknowledge the Johns Hopkins ARVD Program (http://www.arvd.com), which is supported by the Bogle Foundation, the Campanella family, the Wilmerding Endowment, the Dr. Francis P Chiaramonte Foundation, the Healing Hearts Foundation, Boston Scientific, Medtronic, and St Jude Medical. BY Tan was supported by funds from the National Medical Research Council Medical Research Fellowship and the Health Manpower Development Plan Fellowship by the Ministry of Health, Singapore.
Conflicts of Interest
Dr. Hugh Calkins receives honoraria for lectures from Boston Scientific, Medtronic, and St. Jude Medical and is a consultant for Medtronic. The authors have no other potential conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Materials
Below is the link to the electronic supplementary material.
Table S1
Clinical and genetic characteristics of participants. (DOC 42.3 kb)
Fig. S1
Conservation at sites of novel mutations in the Young cohort. Conservation of the mutated amino acid in five novel missense mutations. Amino acids are represented by their standard abbreviations (E Glutamate, K Lysine, G Glycine, T Threonine). ↓ indicates site of mutation. Species are shown by their standard nomenclature. (DOC 41.0 kb)
Fig. S2
Conservation at sites of novel mutations in the Late cohort. Conservation of the mutated amino acid in three novel missense mutations. Amino acids are represented by their standard abbreviations (D aspartate, E glutamate, V valine). ↓ indicates site of mutation. Species are shown by their standard nomenclature. (DOC 31.5 kb)
Rights and permissions
About this article
Cite this article
Tan, B.Y., Jain, R., den Haan, A.D. et al. Shared Desmosome Gene Findings in Early and Late Onset Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. J. of Cardiovasc. Trans. Res. 3, 663–673 (2010). https://doi.org/10.1007/s12265-010-9224-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-010-9224-4